Softbox presents IoT connected cold chain packaging

Softbox presents IoT connected cold chain packaging

Long Crendon, Buckinghamshire, UK, 2nd April 2019 – Softbox, a leading global innovator and provider of temperature control packaging for the life science and logistics industries, has announced the introduction of a new concept to bring IoT and connected digital transformation to the pharmaceutical and clinical trial cold chain distribution.

Softbox is leveraging emerging technologies and incorporating them into its temperature control packaging systems for day-to-day cold chain distribution. These technologies can help make better and quicker decisions, reduce waste in the supply chain and ultimately provide pharmaceutical companies and patients with medications on time, and in the best condition possible.

Softbox’s IoT project, developed in collaboration with market-leading companies, focuses on providing transparency on every step of the cold chain distribution process, from dispatch through to dispensing to the patient.

This new project, in combination with the already available Softbox rental program, solves many of the challenges pharmaceutical companies face today, such as sustainability regulations, cost-reductions, excursion management and real-time visibility of temperature, location, shock and light exposure.

Softbox is presenting this connected IoT project at LogiPharma on the 9th -11th April, in Switzerland.

Richard Wood, Director of Connected Digital Technologies at Softbox commented: “IoT technology brings enhanced transparency, accuracy and responsiveness to the whole delivery cycle. Visibility and traceability are top priorities for the cold-chain logistics industry, Softbox’s new IoT products and services aim to deliver the best combination of packaging and technology for our clients.”

 

About Softbox

Softbox is an award-winning temperature control packaging innovator that has been designing and producing high performance passive temperature control packaging solutions for over 20 years. We offer consistent quality to our clients from our strategically located global manufacturing sites throughout Europe, North America, Latin America and Asia Pacific. We have formed long standing partnerships with the world’s leading pharmaceutical, clinical research, biotech and logistics companies, and apply innovative thinking to overcome the challenges that our clients face in managing the Cold Chain when shipping temperature sensitive clinical trial and commercialised products. For more information about Softbox visit: www.softboxsystems.com

About LogiPharma

LogiPharma is the longest-running supply chain event celebrating its 19th consecutive year in 2019. Since its inception thousands of supply chain professionals from the top pharma, generics and animal health companies took their careers to new levels by learning new skills and making new contacts onsite. Over the years the LogiPharma network of past attendees has grown and grown providing those new to the event access to the most senior pharma supply chain leaders for unique professional development opportunities. For more information visit https://logipharmaeu.wbresearch.com

For all media enquiries

Lisa Preston, Amplify PR

Telephone: +44 (0)1962 435006 or +44 (0)7980 923 531

Email: lisa@amplify-pr.co.uk

TP3 Global receives Royal recognition by winning the Queen’s Awards 2018 for Enterprise

TP3 Global receives Royal recognition by winning the Queen’s Awards 2018 for Enterprise

Birmingham, UK, 23 April 2018 – TP3 Global, a leading global innovator and provider of thermal protection for temperature sensitive cargo, is pleased to announce it has been awarded the 2018 Queen’s Awards for Enterprise in the International Trade category for its globally-recognised Silverskin™ brand.

The Queen’s Awards for Enterprise are the United Kingdom’s most prominent business awards, which commend enterprise excellence. TP3 Global won the recognition for outstanding growth in overseas sales over the past three years. SilverSkinTM has become a major brand in the market, recognised, approved and used by the leading pharmaceutical companies around the world. TP3 Global has seen rapid growth thanks to a strong focus on providing consistent quality and innovative solutions to a worldwide client base.

Clive Wheeldon, President of TP3 Global, commented: “We are extremely proud to achieve the prestigious Queen’s Award for Enterprise for international trade. Our commitment to providing market-leading products, innovation and high-quality customer service has resulted in working with the industry’s leading pharmaceutical companies.

We continue to invest heavily in R&D, global footprint and customer service ensuring we stay at the forefront of the market. We are delighted to see many of the world’s pharmaceutical companies utilise SilverskinTM to maintain the integrity of their products in their supply chain. Our team is very proud to have won a prestigious Queen’s Award that recognises our on-going commitment to innovation and excellence for international trade.”

The Queen’s Awards for Enterprise first began in 1966. They are awarded to businesses for outstanding achievement in four categories International Trade, Innovation, Sustainable Development and also for Promoting Opportunity (through social mobility).

TP3 Global’s commitment to continuous improvement – ISO 9001:2015 and ISO 14001:2015 Certification

TP3 Global’s commitment to continuous improvement – ISO 9001:2015 and ISO 14001:2015 Certification

As innovators of the market, we continually strive to improve all aspects of our business. Our long standing commitment to quality and environmental responsibilities have been well documented, proven by having achieved both ISO 9001:2008 and 14001:2004.

We are delighted to announce that we have once again proven our high levels of standards, and successfully upgraded our previous certificates to ISO 9001:2015 and 14001:2015 standards. Furthermore our industry leading Technical Centre is now included within the scope of both ISO certifications, which underwent major investment in 2017. 

ISO standards are reviewed every five years and revised if needed, this helps ensure they remain useful tools for the marketplace. The challenges faced by business and organisations today are very different from a few decades ago – the 2015 edition has replaced the previous 2004 & 2008 versions to take this new environment into account. Particularly it now puts a greater emphasis on leadership engagement and to address organisational risks and opportunities (known as risk based thinking) in a structured manner.

Nashpal Marwaha, Global Operations Manager commented: “ISO 9001:2015 & 14001:2015 are the latest internationally recognised quality and environmental standards. Our certification demonstrates our commitment to continually improve our management systems to ensure compliance with these standards, and provision of quality thermal protection products and services by TP3 Global.

 

 

 

Softbox acquires TP3 Global to expand worldwide presence and strengthen product portfolio

Softbox acquires TP3 Global to expand worldwide presence and strengthen product portfolio

Long Crendon, Buckinghamshire, UK, 23 January 2018 – Softbox, a leading global innovator and provider of cold chain packaging systems for the pharmaceutical industry, today announces the acquisition of TP3 Global, manufacturers of the globally recognised ‘SilverSkin’ brand. TP3 Global is one of the world’s leading manufacturers of thermal protection covers for the pharmaceutical industry, with operations in the Americas, EMEA, South Asia and Asia Pacific.

 

The combined portfolio of industry-leading passive temperature control packaging systems and thermal protection products will reinforce both companies’ ability to support their customers’ requirements for cold chain packaging solutions, and further expand ability to provide critical technical support on a global basis.

Wayne Langlois, President of Softbox, commented: “I’m extremely proud to welcome TP3 Global to the Softbox family. Our combined capabilities, client relationships, geographic coverage and commitment to innovation, can only strengthen our customer support of temperature controlled distribution. TP3 Global brings a wealth of knowledge and technical expertise from within the thermal protection and logistics industries, and will enable us to provide our customers with a differentiated offering in the temperature controlled packaging market.”

Clive Wheeldon, President of TP3 Global, commented: “The strong cultural fit, complementary products and the potential of combining the outstanding technical capabilities of each company made the decision to join Softbox the next logical step in the development of TP3 Global. The combined global footprint is unrivalled within the temperature controlled packaging industry, enabling us to provide unsurpassed levels of product availability on a local basis worldwide.

“For our customers, the message is very much business as usual, with the same key contacts simply enhancing our ability to provide increased temperature sensitive product protection wherever they need it.”

About Softbox

Softbox is an award-winning temperature control packaging innovator that has been designing and producing high performance passive temperature control packaging solutions for over 20 years. We offer consistent quality to our clients from our strategically located global manufacturing sites throughout Europe, North America, Latin America and Asia Pacific.

We have formed long standing partnerships with the world’s leading pharmaceutical, clinical research, biotech and logistics companies, and apply innovative thinking to overcome the challenges that our clients face in managing the cold chain when shipping temperature sensitive clinical trial and commercialised products.

In 2014, Great Point Partners, a leading health care investment firm, recapitalised Softbox to provide growth financing for the company to continue to execute on its expansion, innovation and global investment strategy to support its clients around the globe.

For more information about Softbox and its innovative packaging, visit www.softboxsystems.com

SilverQuilt: Next generation thermal protection for temperature-sensitive cargo

SilverQuilt: Next generation thermal protection for temperature-sensitive cargo

The SilverQuilt™ achieves superior temperature protection for valuable, sensitive cargo, such as controlled room temperature (15°C to 25°C) pharmaceuticals, due to its specialist composition of multi-layered materials, and is able to protect freight within predefined temperature limits for extended periods during breaks within controlled supply chain lanes. SilverQuilt’s enhanced performance can provide protection for both +15°C to +25°C and +2°C to +8°C pharmaceutical products.

SilverQuilt’s unique construction insulates all areas of the pallet effectively, particularly areas that are at the highest risk of rapid temperature change, such as edges and corners. Its highly reflective outer skin protects against rapid temperature build up when in direct sunlight, extending the protection time when on the tarmac. The superior thermal protection provided by SilverQuilt’s layered construction also extends the periods of protection against cold ambient conditions.

In addition to providing quality thermal protection with reduced temperature exchange, SilverQuilt™ is water resistant and provides resistance against theft. It can also be shipped and delivered cost-effectively due to its compressible design.

Peter Lockett, director at TP3 Global, said: “Breaks in the cold chain are a serious issue for the pharmaceutical supply chain, with valuable stock often sitting on the tarmac for hours at a time. With the introduction of SilverQuilt™, pharmaceutical manufacturers can take a balanced approach, matching cost-effective protection with well managed supply chains.” 

Prior to its launch, SilverQuilt™ underwent testing as part of an extensive research and development process at TP3 Global’s advanced technical centre in Redditch, UK. The material was subjected to hot and cold environmental chamber testing, virtual cold chain simulation and thermal resistance (or R-value) testing. The test data, which was compiled by TP3 Global’s team of packaging technologists, will now be available to customers who undertake a risk-based approach in order to comply with Good Distribution Practice (GDP).

SilverQuilt™ joins TP3 Global’s existing range of qualified thermal protective covers, including SilverSkin™, a range of single-use covers primarily used during air, land and ocean freight.

Peter continued: “Our existing products, such as SilverSkin™, have achieved a solid reputation in the market, being tested, approved and now used by many of the worlds leading pharmaceutical manufacturers. SilverQuilt™ is the next logical step to support customers looking to protect controlled room temperature (CRT) freight with a high-performance cover solution with tighter control limits of +15°C to +25°C. The higher performance enables customers to consider the combination

of controlled lanes and thermal covers for +2°C to +8°C shipments, which was not possible with lower performance thermal covers.

With logistics providers improving the quality of controlled supply chain lanes, there are more options to utilise more cost effective thermal protection on palletised cargo.”

“The launch of SilverQuilt™ arrives at an exciting time for our business, as we continue global expansion and further establish ourselves as one of the leading providers of thermal protection solutions.

“The additional launch of the TP3 Technical Centre this year has increased our capacity to test materials beyond the identification of an R-value. The data this facility provides will support customer decisions on which insulation materials suit certain lanes, support them in taking a risk-based approach towards GDP and provide documented evidence for quality assurance and best practice.” 

Doctor Michael Grillage joins TP3 Global Steering Committee

TP3 Global further strengthens its Healthcare Industry knowledge with the appointment of Doctor Michael Grillage to its Steering Committee.

Doctor Grillage has spent many years within Clinical Trials, Regulation and Product Launch environments.

Having studied medicine at Oxford, achieving an Honors Degree and an MA, Doctor Grillage focused on Phase 3 and 4 clinical trials and formed Ethical Medical Research Associates (EMRA) where the company undertook planning and regulation of Clinical Research Trials for a number of global Pharmaceutical and Healthcare companies.

Clive Wheeldon, TP3 Global Chief Executive Officer stated, “I am privileged to welcome Doctor Grillage to the TP3 Global Steering Committee. His wealth of experience and knowledge in the medical field makes for an excellent addition to the TP3 team”.

We look forward to working with Mike to provide even greater depth of service for our customers.”

About TP3 Global

Focusing on the passive protection of temperature sensitive cargo during transit, TP3 Global Ltd was founded in the UK and has manufacturing bases in the Americas, Europe and Asia. TP3 Global’s SilverSkin range of thermal pallet covers are qualified as GDP compliant and designed for protection of cold chain and controlled room temperature shipment protection world wide. TP3 Global works with the world’s largest Pharmaceutical, Healthcare and Perishable companies who have qualified SilverSkin insulated thermal pallet covers, blankets and quilts to support their cold chain, logistics and supply chain management needs.

Download as PDF